Follow
Valentina R. Garbarino
Valentina R. Garbarino
UT Health San Antonio
Verified email at uthscsa.edu
Title
Cited by
Cited by
Year
Biological aging processes underlying cognitive decline and neurodegenerative disease
MM Gonzales, VR Garbarino, E Pollet, JP Palavicini, DL Kellogg, E Kraig, ...
The Journal of clinical investigation 132 (10), 2022
1092022
Mechanisms of oxidative stress resistance in the brain: lessons learned from hypoxia tolerant extremophilic vertebrates
VR Garbarino, ME Orr, KA Rodriguez, R Buffenstein
Archives of biochemistry and biophysics 576, 8-16, 2015
1062015
Senolytic therapy to modulate the progression of Alzheimer’s disease (SToMP-AD): a pilot clinical trial
MM Gonzales, VR Garbarino, EM Zilli, RC Petersen, JL Kirkland, ...
The journal of prevention of Alzheimer's disease, 1-8, 2022
902022
Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder
VR Garbarino, TL Gilman, LC Daws, GG Gould
Pharmacological research 140, 85-99, 2019
792019
Extended postnatal brain development in the longest-lived rodent: prolonged maintenance of neotenous traits in the naked mole-rat brain
ME Orr, VR Garbarino, A Salinas, R Buffenstein
Frontiers in neuroscience 10, 213874, 2016
512016
Sustained high levels of neuroprotective, high molecular weight, phosphorylated tau in the longest-lived rodent
ME Orr, VR Garbarino, A Salinas, R Buffenstein
Neurobiology of aging 36 (3), 1496-1504, 2015
362015
Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial
MM Gonzales, VR Garbarino, TF Kautz, JP Palavicini, M Lopez-Cruzan, ...
Nature medicine 29 (10), 2481-2488, 2023
292023
A geroscience motivated approach to treat Alzheimer’s disease: senolytics move to clinical trials
MM Gonzales, S Krishnamurthy, V Garbarino, AS Daeihagh, GJ Gillispie, ...
Mechanisms of ageing and development 200, 111589, 2021
222021
Senolytic therapy to modulate the progression of Alzheimer’s Disease (SToMP-AD)–Outcomes from the first clinical trial of senolytic therapy for Alzheimer’s disease
MM Gonzales, VR Garbarino, T Kautz, JP Palavicini, M Lopez-Cruzan, ...
Research square, 2023
182023
Prenatal metformin exposure or organic cation transporter 3 knock-out curbs social interaction preference in male mice
VR Garbarino, TA Santos, AR Nelson, WQ Zhang, CM Smolik, MA Javors, ...
Pharmacological research 140, 21-32, 2019
172019
Phthiraptera and Acari collected from 13 species of Waterfowl from Alabama and Georgia
VR Garbarino, JW Campbell, J O'Brien, HC Proctor, B Dik
Southeastern Naturalist 12 (2), 413-426, 2013
122013
Senolytic therapy to modulate the progression of Alzheimer’s disease (SToMP-AD): a pilot clinical trial. J Prev Alzheimer’s Dis 9: 22–29
MM Gonzales, VR Garbarino, E Marques Zilli
72021
A head‐to‐head comparison between senolytic therapies, dasatinib plus quercetin and fisetin, indicates sex‐and genotype‐specific differences in translationally relevant …
VR Garbarino, S Tran, JE Glassman, JL Kirkland, N Musi, S Seshadri, ...
Alzheimer's & Dementia 16, e047607, 2020
32020
Covid‐19 may have a detrimental impact on sensorimotor function
M Goss, R Bernal, VN Patel, K Li, VR Garbarino, RR Nair, HM Snyder, ...
Alzheimer's & Dementia 19, e083191, 2023
12023
Evaluation of Exploratory Fluid Biomarker Results from a Phase 1 Senolytic Trial in Mild Alzheimer’s Disease
M Orr, V Garbarino, J Palavicini, J Melendez, N Barthélemy, Y He, T Kautz, ...
2024
Disparities in Research Participation within a Multi‐Racial SARS‐CoV‐2 Cohort for Evaluation of Ultrahigh Field (7T) MRI and Clinical Precursors of Alzheimer’s Disease and …
FS Vahidy, AA Hosseini, TD Girard, T Ibrahim, HIL Jacobs, GC Roman, ...
Alzheimer's & Dementia 19, e077318, 2023
2023
Exploration of the tumorigenic, metabolic, and cognitive consequences of tau protein removal
JM Erichsen, VR Garbarino, A Rodriguez, JK Lee, JC Shayne, TC Orr, ...
Alzheimer's & Dementia 19, e073069, 2023
2023
Hippocampal subfield volumes in COVID‐19: a preliminary multicenter study using 7T MRI
T Santini, S Alkateeb, JJ Liou, J Li, OF Adeyemi, GA de Erausquin, ...
Alzheimer's & Dementia 19, e082651, 2023
2023
Lower locus coeruleus integrity in older COVID‐19 survivors: initial findings from an international 7T MRI consortium
HIL Jacobs, T Ibrahim, FS Vahidy, TD Girard, AA Hosseini, S Alkateeb, ...
Alzheimer's & Dementia 19, e080224, 2023
2023
Preliminary neurocognitive finding from a multi‐site study investing long‐term neurological impact of COVID‐19 using ultra‐high field 7 Tesla MRI‐based neuroimaging
JD Tannous, FS Vahidy, R Patira, AM Luckey, MM Gonzales, AA Hosseini, ...
Alzheimer's & Dementia 19, e079210, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20